AVEX heads into its May 20 print riding an unusual wave: a clean sweep of bullish analyst initiations, a cluster of insider purchases at IPO price, and a borrow market that has tightened sharply in just one week.
The analyst story is the clearest signal here. Seven firms — Goldman Sachs, JP Morgan, BofA, Jefferies, Needham, Raymond James, and Baird — all initiated coverage on May 12, every one with a Buy or Outperform rating. Targets range from $32 to $45, with the consensus mean at $35.25 against a current price of $24.87, implying roughly 42% upside in the Street's central case. That is an unusually uniform opening chorus, and it frames the debate heading into the print: can AEVEX's actual numbers validate the enthusiasm?
Insiders were already voting with capital before the analyst wave arrived. On April 16, five insiders bought shares simultaneously at $20 — including Founder and Executive Chairman Brian Raduenz ($1M), CEO Charles Wells, CFO Todd Booth ($260K), and two senior vice presidents. Net insider buying totals $1.48M across 90 days. The stock has since risen 24% from that entry point, suggesting the buys were made into weakness rather than strength.
The borrow market tells a more cautious sub-story. Availability has tightened sharply this week, falling to roughly 100% — meaning the pool of shares available to lend has shrunk to roughly equal the amount already borrowed, compared to over 300% as recently as May 8. Cost to borrow has eased from a spike above 56% in late April to just under 3% now, a significant retreat that signals the earlier squeeze pressure has unwound. Short interest edged up 10.6% on May 15 alone to around 2.47 million shares. The ORTEX short score has climbed to 61.8, its highest reading in the tracked period, though the absence of free-float data makes a precise SI-as-percent-of-float calculation unavailable. Options positioning leans constructive: the put/call ratio has drifted down to 0.49 after touching its 52-week high of 0.75 in early May, suggesting downside hedging has eased into the report.
The one cautionary data point is execution history. A recent note flagged an 8% revenue miss in Q1, attributed to supply chain delays in the defense contracting segment, though the stock has largely recovered from that reaction. AEVEX trades on a P/E of 60x and an EV/EBITDA of 25x — multiples that leave little room for further misses. The earnings report will test whether the company can deliver the kind of operational traction that justifies both the analyst targets and the insider conviction at the IPO price.
See the live data behind this article on ORTEX.
Open AVEX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
